Expression and characterization of cynomolgus monkey cytochrome CYP3A4 in a novel human embryonic kidney cell-based mammalian system

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Sindhuja SelvakumarMurali Subramanian

Abstract

Cynomolgus monkeys are a commonly used species in preclinical drug discovery, and have high genetic similarity to humans, especially for the drug-metabolizing cytochrome P450s. However, species differences are frequently observed in the metabolism of drugs between cynomolgus monkeys and humans, and delineating these differences requires expressed CYPs. Toward this end, cynomolgus monkey CYP3A4 (c3A4) was cloned and expressed in a novel human embryonic kidney 293-6E cell suspension system. Following the preparation of microsomes, the kinetic profiles of five known human CYP3A4 (h3A4) substrates (midazolam, testosterone, terfenadine, nifedipine, and triazolam) were determined. All five substrates were found to be good substrates of c3A4, although some differences were observed in the Km values. Overall, the data suggest a strong substrate similarity between c3A4 and h3A4. Additionally, c3A4 exhibited no activity against non-h3A4 probe substrates, except for a known human CYP2D6 substrate (bufuralol), which suggests potential metabolism of human cytochrome CYP2D6-substrates by c3A4. Ketoconazole and troleandomycin showed similar inhibitory potencies toward c3A4 and h3A4, whereas non-h3A4 inhibitors did not inhibit c3A4 activity. T...Continue Reading

References

Jun 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B Ljungberg, I Nilsson-Ehle
Nov 24, 1999·Archives of Biochemistry and Biophysics·D C MankowskiM P Lawton
Jul 24, 2002·Pharmaceutical Research·Win L Chiou, Paul W Buehler
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kiran C PatkiDavid J Greenblatt
May 25, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert L Walsky, R Scott Obach
Jul 4, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Brian CarrCatherine Booth-Genthe
May 2, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tomohiro NishimuraAkira Tsuji
Sep 14, 2007·Journal of Pharmaceutical Sciences·Hiroshi Komura, Masahiro Iwaki
Feb 21, 2009·Journal of Pharmaceutical Sciences·Masayuki TakahashiShinji Yamashita
Jul 23, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K Iwasaki, Y Uno
Nov 17, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takafumi AkabaneToshio Teramura
May 27, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yasuhiro UnoHiroshi Yamazaki
Jun 30, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tatsuyuki OhtsukaToshiyuki Kume
Sep 4, 2010·Drug Metabolism and Pharmacokinetics·Kazuhide IwasakiHiroshi Yamazaki
Oct 12, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Shotaro UeharaYasuhiro Uno
Feb 10, 2011·Drug Metabolism Reviews·Yasuhiro UnoDavid R Nelson
Apr 29, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Andrew ParkinsonBrian W Ogilvie
Aug 19, 2011·The Journal of Pharmacology and Experimental Therapeutics·Shotaro UeharaYasuhiro Uno
Sep 1, 2011·Drug Metabolism and Pharmacokinetics·Haruka NishimutaSetsuko Komuro
Feb 14, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Noriaki YodaEiji Kashiyama

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.